Short Bowel Syndrome Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: S6C220FE5045EN
Market Monitor Global

Abstracts

Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.

This report contains market size and forecasts of Short Bowel Syndrome in Global, including the following market information:

Global Short Bowel Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Short Bowel Syndrome market was valued at 457.1 million in 2021 and is projected to reach US$ 1330.9 million by 2028, at a CAGR of 16.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

GLP-2 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Short Bowel Syndrome include Takeda, Merck, Emmaus Life Sciences, Nutrinia, GlyPharma Therapeutics, OxThera, Ardelyx, Sancilio & Company and Naia Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Short Bowel Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Short Bowel Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Short Bowel Syndrome Market Segment Percentages, by Type, 2021 (%)

• GLP-2
• Growth Hormone
• Glutamine
• Others

Global Short Bowel Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Short Bowel Syndrome Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global Short Bowel Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Short Bowel Syndrome Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Short Bowel Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Short Bowel Syndrome revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Takeda
• Merck
• Emmaus Life Sciences
• Nutrinia
• GlyPharma Therapeutics
• OxThera
• Ardelyx
• Sancilio & Company
• Naia Pharmaceuticals
• Zealand Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Short Bowel Syndrome Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Short Bowel Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SHORT BOWEL SYNDROME OVERALL MARKET SIZE

2.1 Global Short Bowel Syndrome Market Size: 2021 VS 2028
2.2 Global Short Bowel Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Short Bowel Syndrome Players in Global Market
3.2 Top Global Short Bowel Syndrome Companies Ranked by Revenue
3.3 Global Short Bowel Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Short Bowel Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Short Bowel Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Short Bowel Syndrome Players in Global Market
  3.6.1 List of Global Tier 1 Short Bowel Syndrome Companies
  3.6.2 List of Global Tier 2 and Tier 3 Short Bowel Syndrome Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Short Bowel Syndrome Market Size Markets, 2021 & 2028
  4.1.2 GLP-2
  4.1.3 Growth Hormone
  4.1.4 Glutamine
  4.1.5 Others
4.2 By Type - Global Short Bowel Syndrome Revenue & Forecasts
  4.2.1 By Type - Global Short Bowel Syndrome Revenue, 2017-2022
  4.2.2 By Type - Global Short Bowel Syndrome Revenue, 2023-2028
  4.2.3 By Type - Global Short Bowel Syndrome Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Short Bowel Syndrome Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
5.2 By Application - Global Short Bowel Syndrome Revenue & Forecasts
  5.2.1 By Application - Global Short Bowel Syndrome Revenue, 2017-2022
  5.2.2 By Application - Global Short Bowel Syndrome Revenue, 2023-2028
  5.2.3 By Application - Global Short Bowel Syndrome Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Short Bowel Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Short Bowel Syndrome Revenue & Forecasts
  6.2.1 By Region - Global Short Bowel Syndrome Revenue, 2017-2022
  6.2.2 By Region - Global Short Bowel Syndrome Revenue, 2023-2028
  6.2.3 By Region - Global Short Bowel Syndrome Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Short Bowel Syndrome Revenue, 2017-2028
  6.3.2 US Short Bowel Syndrome Market Size, 2017-2028
  6.3.3 Canada Short Bowel Syndrome Market Size, 2017-2028
  6.3.4 Mexico Short Bowel Syndrome Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Short Bowel Syndrome Revenue, 2017-2028
  6.4.2 Germany Short Bowel Syndrome Market Size, 2017-2028
  6.4.3 France Short Bowel Syndrome Market Size, 2017-2028
  6.4.4 U.K. Short Bowel Syndrome Market Size, 2017-2028
  6.4.5 Italy Short Bowel Syndrome Market Size, 2017-2028
  6.4.6 Russia Short Bowel Syndrome Market Size, 2017-2028
  6.4.7 Nordic Countries Short Bowel Syndrome Market Size, 2017-2028
  6.4.8 Benelux Short Bowel Syndrome Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Short Bowel Syndrome Revenue, 2017-2028
  6.5.2 China Short Bowel Syndrome Market Size, 2017-2028
  6.5.3 Japan Short Bowel Syndrome Market Size, 2017-2028
  6.5.4 South Korea Short Bowel Syndrome Market Size, 2017-2028
  6.5.5 Southeast Asia Short Bowel Syndrome Market Size, 2017-2028
  6.5.6 India Short Bowel Syndrome Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Short Bowel Syndrome Revenue, 2017-2028
  6.6.2 Brazil Short Bowel Syndrome Market Size, 2017-2028
  6.6.3 Argentina Short Bowel Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Short Bowel Syndrome Revenue, 2017-2028
  6.7.2 Turkey Short Bowel Syndrome Market Size, 2017-2028
  6.7.3 Israel Short Bowel Syndrome Market Size, 2017-2028
  6.7.4 Saudi Arabia Short Bowel Syndrome Market Size, 2017-2028
  6.7.5 UAE Short Bowel Syndrome Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Takeda
  7.1.1 Takeda Corporate Summary
  7.1.2 Takeda Business Overview
  7.1.3 Takeda Short Bowel Syndrome Major Product Offerings
  7.1.4 Takeda Short Bowel Syndrome Revenue in Global Market (2017-2022)
  7.1.5 Takeda Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Short Bowel Syndrome Major Product Offerings
  7.2.4 Merck Short Bowel Syndrome Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Emmaus Life Sciences
  7.3.1 Emmaus Life Sciences Corporate Summary
  7.3.2 Emmaus Life Sciences Business Overview
  7.3.3 Emmaus Life Sciences Short Bowel Syndrome Major Product Offerings
  7.3.4 Emmaus Life Sciences Short Bowel Syndrome Revenue in Global Market (2017-2022)
  7.3.5 Emmaus Life Sciences Key News
7.4 Nutrinia
  7.4.1 Nutrinia Corporate Summary
  7.4.2 Nutrinia Business Overview
  7.4.3 Nutrinia Short Bowel Syndrome Major Product Offerings
  7.4.4 Nutrinia Short Bowel Syndrome Revenue in Global Market (2017-2022)
  7.4.5 Nutrinia Key News
7.5 GlyPharma Therapeutics
  7.5.1 GlyPharma Therapeutics Corporate Summary
  7.5.2 GlyPharma Therapeutics Business Overview
  7.5.3 GlyPharma Therapeutics Short Bowel Syndrome Major Product Offerings
  7.5.4 GlyPharma Therapeutics Short Bowel Syndrome Revenue in Global Market (2017-2022)
  7.5.5 GlyPharma Therapeutics Key News
7.6 OxThera
  7.6.1 OxThera Corporate Summary
  7.6.2 OxThera Business Overview
  7.6.3 OxThera Short Bowel Syndrome Major Product Offerings
  7.6.4 OxThera Short Bowel Syndrome Revenue in Global Market (2017-2022)
  7.6.5 OxThera Key News
7.7 Ardelyx
  7.7.1 Ardelyx Corporate Summary
  7.7.2 Ardelyx Business Overview
  7.7.3 Ardelyx Short Bowel Syndrome Major Product Offerings
  7.7.4 Ardelyx Short Bowel Syndrome Revenue in Global Market (2017-2022)
  7.7.5 Ardelyx Key News
7.8 Sancilio & Company
  7.8.1 Sancilio & Company Corporate Summary
  7.8.2 Sancilio & Company Business Overview
  7.8.3 Sancilio & Company Short Bowel Syndrome Major Product Offerings
  7.8.4 Sancilio & Company Short Bowel Syndrome Revenue in Global Market (2017-2022)
  7.8.5 Sancilio & Company Key News
7.9 Naia Pharmaceuticals
  7.9.1 Naia Pharmaceuticals Corporate Summary
  7.9.2 Naia Pharmaceuticals Business Overview
  7.9.3 Naia Pharmaceuticals Short Bowel Syndrome Major Product Offerings
  7.9.4 Naia Pharmaceuticals Short Bowel Syndrome Revenue in Global Market (2017-2022)
  7.9.5 Naia Pharmaceuticals Key News
7.10 Zealand Pharma
  7.10.1 Zealand Pharma Corporate Summary
  7.10.2 Zealand Pharma Business Overview
  7.10.3 Zealand Pharma Short Bowel Syndrome Major Product Offerings
  7.10.4 Zealand Pharma Short Bowel Syndrome Revenue in Global Market (2017-2022)
  7.10.5 Zealand Pharma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Short Bowel Syndrome Market Opportunities & Trends in Global Market
Table 2. Short Bowel Syndrome Market Drivers in Global Market
Table 3. Short Bowel Syndrome Market Restraints in Global Market
Table 4. Key Players of Short Bowel Syndrome in Global Market
Table 5. Top Short Bowel Syndrome Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Short Bowel Syndrome Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Short Bowel Syndrome Revenue Share by Companies, 2017-2022
Table 8. Global Companies Short Bowel Syndrome Product Type
Table 9. List of Global Tier 1 Short Bowel Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Short Bowel Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Short Bowel Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Short Bowel Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Short Bowel Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Short Bowel Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Short Bowel Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Short Bowel Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Short Bowel Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Short Bowel Syndrome Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Short Bowel Syndrome Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Short Bowel Syndrome Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Short Bowel Syndrome Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Short Bowel Syndrome Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Short Bowel Syndrome Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Short Bowel Syndrome Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Short Bowel Syndrome Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Short Bowel Syndrome Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Short Bowel Syndrome Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Short Bowel Syndrome Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Short Bowel Syndrome Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Corporate Summary
Table 31. Takeda Short Bowel Syndrome Product Offerings
Table 32. Takeda Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Short Bowel Syndrome Product Offerings
Table 35. Merck Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 36. Emmaus Life Sciences Corporate Summary
Table 37. Emmaus Life Sciences Short Bowel Syndrome Product Offerings
Table 38. Emmaus Life Sciences Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 39. Nutrinia Corporate Summary
Table 40. Nutrinia Short Bowel Syndrome Product Offerings
Table 41. Nutrinia Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 42. GlyPharma Therapeutics Corporate Summary
Table 43. GlyPharma Therapeutics Short Bowel Syndrome Product Offerings
Table 44. GlyPharma Therapeutics Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 45. OxThera Corporate Summary
Table 46. OxThera Short Bowel Syndrome Product Offerings
Table 47. OxThera Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 48. Ardelyx Corporate Summary
Table 49. Ardelyx Short Bowel Syndrome Product Offerings
Table 50. Ardelyx Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 51. Sancilio & Company Corporate Summary
Table 52. Sancilio & Company Short Bowel Syndrome Product Offerings
Table 53. Sancilio & Company Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 54. Naia Pharmaceuticals Corporate Summary
Table 55. Naia Pharmaceuticals Short Bowel Syndrome Product Offerings
Table 56. Naia Pharmaceuticals Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)
Table 57. Zealand Pharma Corporate Summary
Table 58. Zealand Pharma Short Bowel Syndrome Product Offerings
Table 59. Zealand Pharma Short Bowel Syndrome Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Short Bowel Syndrome Segment by Type in 2021
Figure 2. Short Bowel Syndrome Segment by Application in 2021
Figure 3. Global Short Bowel Syndrome Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Short Bowel Syndrome Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Short Bowel Syndrome Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Short Bowel Syndrome Revenue in 2021
Figure 8. By Type - Global Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 9. By Application - Global Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 10. By Region - Global Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 11. By Country - North America Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 12. US Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 16. Germany Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 17. France Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 24. China Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 28. India Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 30. Brazil Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Short Bowel Syndrome Revenue Market Share, 2017-2028
Figure 33. Turkey Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Short Bowel Syndrome Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Emmaus Life Sciences Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Nutrinia Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlyPharma Therapeutics Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. OxThera Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Ardelyx Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sancilio & Company Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Naia Pharmaceuticals Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zealand Pharma Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)